Drug-coated balloons (DCBs) are used commonly for delivering drug into diseased arteries.
When applied on the inner surface of an artery, drug is transported from the balloon into the …

Balloon angioplasty followed by local delivery of antiproliferative drugs to target tissue is
increasingly being considered for the treatment of obstructive arterial disease, and yet there …

Angioplasty with drug-coated balloons (DCBs) using excipients as drug carriers is emerging
as a potentially viable strategy demonstrating clinical efficacy and proposing additional …

In this article we investigate the role of anisotropic diffusion on the resulting arterial wall drug
distribution following stent-based delivery. The arterial wall is known to exhibit anisotropic …

Drug-eluting stents have revolutionised the treatment of coronary artery disease. These
small medical devices have attracted much interest over the past decade from biologists …

Drug-coated balloon (DCB) angioplasty is one of the potential approaches to alleviating in-
stent restenosis and treating peripheral artery disease. An in-silico model has been …

A new mass transfer model has been formulated and implemented for predicting the
penetration of liquid medication into an arterial wall. The model takes separate account of …

The focus of this paper is to propose, model, and characterize a means of accelerating the
rate of delivery of therapeutic drugs to human tissues. The investigated means is a …

The hallmark of drug-coated balloon (DCB) therapy for the treatment of peripheral vascular
disease is that it allows for reopening of the narrowed lumen and local drug delivery without …

Stents are often used to maintain the diameter of the coronary artery lumen. The insertion of
a stent into an artery often results in the accumulation of scar tissue in response to the stent's …